2014 BioSummit presents new learning opportunities

On March 26, the Oklahoma Biosciences Association presents the 2014 BioSummit and BioScience Awards Dinner at the Skirvin Hilton Hotel.
Oklahoman Published: March 16, 2014

Almost 10 years ago I stepped into a conference room at Oklahoma City’s Cox Center and found myself in a new world. It was a conference called BioLife presented by i2E Inc.

As a newspaper reporter, then new to the bioscience beat, the BioLife conference lifted a curtain for me. I met scientists and entrepreneurs who would become valued sources and remain so today. I heard presentations that sparked my interest in how companies start from scratch and grow into multimillion dollar corporations, and how a new drug is developed in the lab.

A similar learning opportunity presents itself on March 26, when the Oklahoma Biosciences Association presents the 2014 BioSummit and BioScience Awards Dinner at the Skirvin Hilton Hotel.

This time the emphasis will be on the fundamentals of obtaining funding for your new bioscience technology, positioning for investment and the key elements of making your technology attract investors in the industry.

The BioSummit will kick off with a session on what type of funding is available in the state, what angel investors want to see, investment terminology and term sheets, and how to find and receive private philanthropic funding.

Presenting the opening session will be Scott Meacham, president and CEO of i2E Inc.; Dr. William Paiva, manager of the Oklahoma Life Science Fund, and Von Allen, director of development for the University of Oklahoma’s Stephenson Cancer Center.

After a networking luncheon, there will be a panel discussion on the importance of partnerships and exit strategies featuring Doug Branch, a patent attorney and director at PhillipsMurrah law firm; Clayton Duncan, CEO at Accele BioPharma; and Dennis Schafer, president and CEO at Altheus Therapeutics.

“We’re pleased to be able to present a funding primer from a wide range of industry perspectives, both as investors and entrepreneurs,” said Meacham, who is also president and CEO of the Oklahoma Bioscience Association.

“The BioSummit will be a great learning opportunity for anyone working to advance a new therapy or a bioscience startup,” Meacham said.


Oklahoma BioScience Association

The mission of the Oklahoma Bioscience Association is to promote the growth of biosciences in Oklahoma through partnership building, education and outreach, networking, policy development and publicity. It is supported by 32 organizations from across the state.

Trending Now


  1. 1
    College of Charleston president orders second investigation of Doug Wojcik
  2. 2
    Joe Paterno's son Jay sues Penn State for 'improper termination'
  3. 3
    Former Dallas Cowboys running back Robert Newhouse dead at 64
  4. 4
    Oklahoma man gets consecutive 20-year terms for rapes of intellectually challenged classmates
  5. 5
    Angels won't cap former OU pitcher Garrett Richards' innings
+ show more